The estimated Net Worth of Christopher B Begley is at least $401 Tausend dollars as of 28 August 2023. Mr. Begley owns over 1,000 units of Hanger Inc stock worth over $66,269 and over the last 21 years he sold HNGR stock worth over $0. In addition, he makes $335,007 as Non-Executive Chairman of the Board at Hanger Inc.
Christopher has made over 3 trades of the Hanger Inc stock since 2004, according to the Form 4 filled with the SEC. Most recently he bought 1,000 units of HNGR stock worth $117,110 on 28 August 2023.
The largest trade he's ever made was exercising 29,999 units of Hanger Inc stock on 17 February 2004 worth over $1,060,765. On average, Christopher trades about 568 units every 121 days since 2003. As of 28 August 2023 he still owns at least 3,540 units of Hanger Inc stock.
You can see the complete history of Mr. Begley stock trades at the bottom of the page.
Christopher B. Begley serves as Non-Executive Chairman of the Board of the Company. Mr. Begley is the retired Executive Chairman and Chief Executive Officer of Hospira, Inc., a global provider of injectable drugs and infusion technology. Mr. Begley served as Executive Chairman of the Board of Hospira from May 2007 until January 2012, and served as Chief Executive Officer from April 30, 2004, when Hospira was spun off from Abbott Laboratories, to March 2011. Prior to that, Mr. Begley served in various positions at Abbott from 1986 to April 2004, leaving Abbott as Senior Vice President of its Hospital Products division. Mr. Begley also serves as a director of Zimmer/Biomet Holdings Inc., a medical device company. Mr. Begley served as non-executive Chairman of the Board of Adtalem Global Education Inc. (formerly known as DeVry Education Group Inc.), from November 2014 to November 2017, and as a director of Adtalem from November 2011 to November 2017. Mr. Begley previously served as non-executive Chairman of the Board of The Hillshire Brands Company from June 2012 to August 2014, and served as a director of the Sara Lee Corporation from October 2006 to May 2012. Mr. Begley earned a bachelor’s degree from Western Illinois University and an M.B.A. from Northern Illinois University. Mr. Begley’s experience as a former Chief Executive Officer of Hospira, Inc., a publicly traded health care company, as well as his experience as a director of other public companies and his background in health care companies generally, led to the conclusion that he should serve as our Chairman of the Board.
As the Non-Executive Chairman of the Board of Hanger Inc, the total compensation of Christopher Begley at Hanger Inc is $335,007. There are 10 executives at Hanger Inc getting paid more, with Vinit Asar having the highest compensation of $4,940,250.
Christopher Begley is 68, he's been the Non-Executive Chairman of the Board of Hanger Inc since 2018. There are 1 older and 23 younger executives at Hanger Inc. The oldest executive at Hanger Inc is Richard Pettingill, 71, who is the Independent Director.
Christopher's mailing address filed with the SEC is 345, East Main Street, Warsaw, Kosciusko County, Indiana, 46580, United States.
Over the last 7 years, insiders at Hanger Inc have traded over $2,332,397 worth of Hanger Inc stock and bought 2,700 units worth $51,246 . The most active insiders traders include Thomas C Freyman, Stephen E Hare und Cynthia L Lucchese. On average, Hanger Inc executives and independent directors trade stock every 72 days with the average trade being worth of $339,319. The most recent stock trade was executed by Thomas E Kiraly on 15 March 2022, trading 8,750 units of HNGR stock currently worth $167,650.
About Hanger, Inc.- Hanger, Inc. delivers orthotic and prosthetic (O&P) patient care, and distributes O&P products and rehabilitative solutions to the broader market. Hanger's Patient Care segment is the largest owner and operator of O&P patient care clinics withapproximately 800locationsnationwide. Through its Products & Services segment, Hanger distributes branded and private label O&P devices, products and components, and provides rehabilitative solutions. With nearly 160 years of clinical excellence and innovation, Hanger's vision is to lead the orthotic and prosthetic markets by providing superior patient care, outcomes, services and value.
Hanger Inc executives and other stock owners filed with the SEC include: